Envestnet Asset Management’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Buy |
70,478
+707
| +1% | +$14.4K | ﹤0.01% | 3040 |
|
|
2025
Q1 | $1.4M | Sell |
69,771
-3,573
| -5% | -$71.5K | ﹤0.01% | 2977 |
|
|
2024
Q4 | $1.95M | Buy |
73,344
+5,958
| +9% | +$159K | ﹤0.01% | 2695 |
|
|
2024
Q3 | $1.92M | Buy |
67,386
+20,289
| +43% | +$579K | ﹤0.01% | 2684 |
|
|
2024
Q2 | $1.03M | Buy |
47,097
+1,170
| +3% | +$25.5K | ﹤0.01% | 3030 |
|
|
2024
Q1 | $1.02M | Sell |
45,927
-4,100
| -8% | -$90.8K | ﹤0.01% | 3021 |
|
|
2023
Q4 | $1.08M | Sell |
50,027
-3,956
| -7% | -$85.4K | ﹤0.01% | 2889 |
|
|
2023
Q3 | $912K | Buy |
53,983
+18,469
| +52% | +$312K | ﹤0.01% | 2879 |
|
|
2023
Q2 | $487K | Buy |
35,514
+10,849
| +44% | +$149K | ﹤0.01% | 3224 |
|
|
2023
Q1 | $560K | Buy |
24,665
+2,273
| +10% | +$51.6K | ﹤0.01% | 3062 |
|
|
2022
Q4 | $527K | Sell |
22,392
-254
| -1% | -$5.98K | ﹤0.01% | 3073 |
|
|
2022
Q3 | $591K | Buy |
22,646
+48
| +0.2% | +$1.25K | ﹤0.01% | 2909 |
|
|
2022
Q2 | $496K | Sell |
22,598
-16,178
| -42% | -$355K | ﹤0.01% | 3053 |
|
|
2022
Q1 | $1.74M | Buy |
38,776
+5,337
| +16% | +$239K | ﹤0.01% | 2286 |
|
|
2021
Q4 | $1.43M | Buy |
33,439
+441
| +1% | +$18.9K | ﹤0.01% | 2379 |
|
|
2021
Q3 | $2.19M | Buy |
32,998
+2,576
| +8% | +$171K | ﹤0.01% | 2033 |
|
|
2021
Q2 | $2.23M | Buy |
30,422
+22,569
| +287% | +$1.66M | ﹤0.01% | 1981 |
|
|
2021
Q1 | $538K | Buy |
+7,853
| New | +$538K | ﹤0.01% | 2800 |
|